Clinical Trial Update: Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing parotid-sparing intensity-modulated radiation therapy with conventional radiation therapy for oropharyngeal or hypopharyngeal c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Hypopharyngeal Cancer
• Oropharyngeal Cancer

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Head and Neck Cancer, Radiation Toxicity | Phase 3 | Status: UNKNOWN